Greenlane Holdings, Inc. — Form 8-K Summary
Business Context and Reporting Period
Greenlane Holdings, Inc. filed a Form 8-K dated February 25, 2022, reporting a Nasdaq minimum-bid-price deficiency and certain unregistered equity issuances. The filing was signed on March 2, 2022. No quarterly or annual financial results are included.
Key Financial and Capitalization Information
- As of February 25, 2022, the Company had 92,246,482 shares of Class A common stock issued and outstanding.
- The filing provides no revenue, profit, cash flow, margin, debt, cash balance, or liquidity figures.
- The Company issued 3,030,303 Class A common shares on February 25, 2022, to DaVinci and certain affiliates as contingent consideration after DaVinci achieved specified financial benchmarks.
- The Company previously issued 795,523 Class A common shares on January 14, 2022, to Eyce and certain affiliates as contingent consideration after Eyce achieved specified financial benchmarks.
- The Company issued 55,770 shares on December 20, 2021, 500,000 shares on January 6, 2022, and 51,004 shares on January 14, 2022, upon redemptions of equal numbers of common units in Greenlane Holdings, LLC.
- The reported issuances were made under the Securities Act Section 4(a)(2) exemption or Regulation D.
Material Changes Versus the Prior Comparable Period
- The filing states that, after the DaVinci issuance, the Company had issued Class A common stock in excess of 5% of the outstanding shares reported in its September 30, 2021 Form 10-Q.
- The issuances increased the outstanding Class A share count and resulted in equity dilution for existing holders. The filing text does not provide a pro forma ownership percentage or fully diluted share count.
Nasdaq Listing Deficiency, Outlook, and Risks
- Nasdaq notified the Company on February 25, 2022, that the closing bid price of its Class A common stock had remained below $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
- The deficiency had no immediate effect on trading; the shares continued to trade on The Nasdaq Capital Market under the symbol GNLN.
- The Company had until August 24, 2022, to regain compliance. Compliance could be restored if the bid price closed at or above $1.00 for at least 10 consecutive business days.
- The Company stated that it would monitor the bid price and consider available alternatives, including a potential reverse stock split. Any reverse split intended to cure the deficiency would need to be completed no later than 10 business days before August 24, 2022.
- If the Company failed to regain compliance by August 24, 2022, it might qualify for a second 180-calendar-day compliance period, subject to meeting Nasdaq’s other applicable requirements and notifying Nasdaq of its intent to cure the deficiency.
- Failure to regain compliance could ultimately place the Company’s Nasdaq listing at risk.
Most Important Facts to Verify
- Whether the Company regained compliance with Nasdaq’s $1.00 minimum bid-price requirement or received an additional compliance period.
- Whether a reverse stock split or another capital restructuring was implemented.
- The final share count and dilution resulting from the Eyce, DaVinci, and operating-company unit redemption transactions.
- The financial benchmarks underlying the contingent consideration issued to Eyce and DaVinci.
- The Company’s subsequent revenue, cash, debt, liquidity, and operating performance, which are not reported in this filing.